Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2b Diabetic Kidney Disease Study

ClinicalTrials.gov ID: NCT04170543

Public ClinicalTrials.gov record NCT04170543. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 1:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects With Diabetic Kidney Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects with Diabetic Kidney Disease

Study identification

NCT ID
NCT04170543
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
609 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 101 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 17, 2019
Primary completion
May 15, 2023
Completion
May 15, 2023
Last update posted
Jul 9, 2024

2019 – 2023

United States locations

U.S. sites
49
U.S. states
24
U.S. cities
45
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209
Research Site Huntsville Alabama 35805
Research Site Mesa Arizona 85210
Research Site Alhambra California 91801
Research Site Glendale California 91204
Research Site Granada Hills California 91344
Research Site Huntington Park California 90255
Research Site Northridge California 91324
Research Site Sacramento California 95821
Research Site San Diego California 92123
Research Site San Dimas California 91773
Research Site Vacaville California 95687
Research Site Fleming Island Florida 32003
Research Site Hialeah Florida 33016
Research Site Jacksonville Florida 32204
Research Site Miami Florida 33015
Research Site Atlanta Georgia 30338
Research Site Honolulu Hawaii 96814
Research Site Chicago Illinois 60607
Research Site Chicago Illinois 60643
Research Site Iowa City Iowa 52242
Research Site Manhattan Kansas 66502
Research Site Topeka Kansas 66606
Research Site Wichita Kansas 67214
Research Site Flint Michigan 48504
Research Site Henderson Nevada 89014
Research Site Las Vegas Nevada 89129
Research Site Berlin New Jersey 08009
Research Site Charlotte North Carolina 28204
Research Site Greensboro North Carolina 27408
Research Site Greenville North Carolina 27834
Research Site Morehead City North Carolina 28557
Research Site Maumee Ohio 43537
Research Site Oklahoma City Oklahoma 73116
Research Site Bethlehem Pennsylvania 18017
Research Site East Providence Rhode Island 02915
Research Site Columbia South Carolina 29203
Research Site Memphis Tennessee 38119
Research Site Cypress Texas 77429
Research Site Houston Texas 77004
Research Site Houston Texas 77079
Research Site Katy Texas 77450
Research Site San Antonio Texas 78212
Research Site San Antonio Texas 78229
Research Site San Antonio Texas 78251
Research Site St. George Utah 84790
Research Site Burke Virginia 22015
Research Site Tacoma Washington 98405
Research Site Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04170543, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 9, 2024 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04170543 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →